Its expression is usually limited to granulocytes and their precursors [37]; however, CD66c can also be expressed on blasts in BCP-ALL and is the most frequently expressed myeloid antigen in BCP-ALL. This evidence concerns the gene CEACAM6 and acute lymphoblastic leukemia.